Navigation Links
Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
Date:10/4/2007

e Company, LLC.

About AEGR-733

AEGR-733 is a novel proprietary MTP-inhibitor under development for the treatment of dyslipidemia (abnormal lipid levels in the bloodstream). Inhibiting the MTP enzyme reduces blood levels of cholesterol and triglyceride by limiting the production of lipoproteins from the intestine and liver. In the United States alone, nearly 100 million adults have total blood cholesterol values of 200 mg/dL and higher, and 34.5 million have levels of 240 and above. Current guidelines recommend that appropriate LDL levels in patients at high risk of cardiovascular disease should be less than 100 mg/dL, or below 70 mg/dL for very high-risk patients. Under these guidelines, 36 million people would be eligible for treatment. Standard therapies, such as statins and cholesterol absorption inhibitors, do not effectively lower LDL-C to target levels in a significant number of patients.

About Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals, Inc. is a privately held specialty pharmaceutical company focused on the development and commercialization of promising pharmaceuticals to treat cardiovascular and metabolic disease. The Company's initial focus is on hyperlipidemia. Its most advanced products have demonstrated significant LDL lowering activity in human trials and are currently in Phase II testing.

Contact

Emily Poe, Vox Medica Health-care Public Relations Group

(t) 215-238-8500 ext 1153

(e) epoe@voxmedica.com


'/>"/>
SOURCE Aegerion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
3. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
4. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
5. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
8. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
9. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
10. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
11. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2008)... 2008 Faces of Influenza survey underscores that m...uenza; Mother and Gold Medalist Kristi Yamaguchi j...RNewswire/ -- While 78 percent of mothers in the U...tially life-threatening disease that can strike an...ll get vaccinated this season, according to a new ...
(Date:11/13/2008)...itional Supplements Prior to Surgery, ARLINGTON H...dentifying,malnutrition before surgery in massive ...significantly decrease surgical complications, acc...ost patient energy levels,according to a study in...Surgery(R), the official medical journal of the Am...
(Date:11/12/2008)...h James D. Watson, Marilyn & James Simons and,Sher..., Md., Nov. 12 J. Craig...aig Venter Institute (JCVI), was,awarded the Doubl...CSHL) on,November 6th at a gala event in New York ... along with Dr. James D.,Watson for making each of...
(Date:11/12/2008)... Study and New Data Suggesting Need for Improved ...l Meeting -, EXTON, Pa., Nov. 12 /PRNewswire-Firs... today announced the presentation of data from its...tudy Cinryze(TM) C1 inhibitor,therapy successfully...(HAE),attacks seen in the study through the date o...
Breaking Medicine Technology:Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 3ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 4ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 5ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 6Raptor Pharmaceuticals Corp Initiates Phase IIa Clinical Study for Convivia 28TM 29 1856 1Raptor Pharmaceuticals Corp Initiates Phase IIa Clinical Study for Convivia 28TM 29 1856 2Raptor Pharmaceuticals Corp Initiates Phase IIa Clinical Study for Convivia 28TM 29 1856 3Raptor Pharmaceuticals Corp Initiates Phase IIa Clinical Study for Convivia 28TM 29 1856 4Raptor Pharmaceuticals Corp Initiates Phase IIa Clinical Study for Convivia 28TM 29 1856 55th Annual World Health Care Congress Kicks off April 21 With Obama Clinton McCain Health Care Policy Advisor Presidential Health Care Agenda Forum 17263 15th Annual World Health Care Congress Kicks off April 21 With Obama Clinton McCain Health Care Policy Advisor Presidential Health Care Agenda Forum 17263 2 C O R R E C T I O N Mobidiag Ltd 4718 1 C O R R E C T I O N Mobidiag Ltd 4718 2Vernalis and Paul Capital Healthcare Sign euro 18 4 Million Financing Agreement 4717 1Vernalis and Paul Capital Healthcare Sign euro 18 4 Million Financing Agreement 4717 2Vernalis and Paul Capital Healthcare Sign euro 18 4 Million Financing Agreement 4717 3
(Date:11/21/2008)... Calif., Nov. 21 Album Creative St...launches a new program offering big brand marketin...the large, expensive ad agency process and service...ry hands-on approach," says Matt Parker, Creative ...ines experience and proven brand-building techniqu...
(Date:11/21/2008)...E, Fla. -- A Florida State University College of M...covered an important new layer of regulation in th...er understanding of the way cancer begins. , Wan...t the College of Medicine, said the findings will ... could lead to the design of new drugs that kill c...
(Date:11/21/2008)... Nov. 21 The Providence ...nced that Craig A. Norris, the Company,s,Chief Op...,s Board of,Directors. Mr. Norris, appointment f...on of Steven I. Geringer and returns the board to ...mmittee of the Board. , Mr. Norris, age 41,...
(Date:11/21/2008)...one day lead to a novel technique to combat cancer...althDay News) -- Belgian researchers have discover...of sugar for food, and this might lead to new trea...urvive and proliferate, all cells in the body need...[glucose], a process that requires oxygen. Compare...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2
...ugs (NSAIDs) are known to enable manifold benefits...ead carefully, evaluating potential risks before s...rding to a diverse expert panel.// Gastrointestin...of NSAID use that could mean complications in both...
...ineered mice has revealed that the dreaded white b...or transplants may also help prevent such damage//...chers have long known that when blood flow is cut ...kidneys or other organs, immune system cells calle...
...immune systems of fish and mammals in the form of ...of the immune system //has been discovered by rese... of Veterinary Medicine. Their studies link the e...in mammals, where B cells produce antibodies to fi...
...ter has become the first hospital in the region to...h doctors believe will change the standard of care...R/Cath Lab, the state-of-the-art operating suite h... devices necessary to perform open-heart surgeries...
Other Medicine News:Health News:Nonsteroidal anti-inflammatory drugs could cause gastrointestinal complications. 2Health News:Nonsteroidal anti-inflammatory drugs could cause gastrointestinal complications. 3Health News:Study Reveals Effects of WBCs on Transplanted Kidney 2Health News:Study Reveals Effects of WBCs on Transplanted Kidney 3Health News:Link between Fish and Mammal Immune Systems Revealed by Killer B cells 2Health News:Link between Fish and Mammal Immune Systems Revealed by Killer B cells 3Health News:A New Approach to Heart Bypass Surgery Provides Patients with 'One-stop Shopping' 2Health News:A New Approach to Heart Bypass Surgery Provides Patients with 'One-stop Shopping' 3Health News:A New Approach to Heart Bypass Surgery Provides Patients with 'One-stop Shopping' 4
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: